Based on this widely accepted assumption and on our observation that WAVE3 is expressed at very low levels in the blood cells, we hypothesized that increased WAVE3 levels in the blood of metastatic BC patients might be a direct result of the presence of CTCs in the circulating blood of these metastatic BC patients. The gene discussed is WASF3; the disease is breast cancer.